Featured Intra-Cellular Therapies (ITCI) Announces $350M Public Offering of Common Stock Intra-Cellular proposes $350 million underwritten public offering. In addition, with the update of positive final-phase test results for a treatment
5 Active Stocks to Trade Today The market rebounded yesterday after several days of declines. Tech stocks drove the rebound rally with the Nasdaq advancing 2.7%,